Global B-Cell Non-Hodgkin's Lymphoma Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 90

Published Date: 04 Nov 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The B-Cell Non-Hodgkin's Lymphoma Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global B-Cell Non-Hodgkin's Lymphoma Drug size is estimated to be USD  million in 2026 from USD  million in 2020, with a change  % between 2020 and 2021. The global B-Cell Non-Hodgkin's Lymphoma Drug market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
B-Cell Non-Hodgkin's Lymphoma Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Oral
    Injection

Market segment by Application, can be divided into
    Hospital
    Retail Pharmacy
    Other

Market segment by players, this report covers
    Roche
    Gilead Sciences
    TG Therapeutics
    Bayer
    Secura Bio
    Epizyme
    Eisai
    Acrotech Biopharma
    Teva
    Eagle Pharmaceuticals
    MundiPharma

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe B-Cell Non-Hodgkin's Lymphoma Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of B-Cell Non-Hodgkin's Lymphoma Drug, with revenue, gross margin and global market share of B-Cell Non-Hodgkin's Lymphoma Drug from 2019 to 2021.
Chapter 3, the B-Cell Non-Hodgkin's Lymphoma Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and B-Cell Non-Hodgkin's Lymphoma Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe B-Cell Non-Hodgkin's Lymphoma Drug research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of B-Cell Non-Hodgkin's Lymphoma Drug
    1.2 Classification of B-Cell Non-Hodgkin's Lymphoma Drug by Type
        1.2.1 Overview: Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Type in 2020
        1.2.3 Oral
        1.2.4 Injection
    1.3 Global B-Cell Non-Hodgkin's Lymphoma Drug Market by Application
        1.3.1 Overview: Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
        1.3.4 Other
    1.4 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size & Forecast
    1.5 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast by Region
        1.5.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region, (2016-2021)
        1.5.3 North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Prospect (2016-2026)
        1.5.4 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Prospect (2016-2026)
        1.5.6 South America B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 B-Cell Non-Hodgkin's Lymphoma Drug Market Drivers
        1.6.2 B-Cell Non-Hodgkin's Lymphoma Drug Market Restraints
        1.6.3 B-Cell Non-Hodgkin's Lymphoma Drug Trends Analysis

2 Company Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.1.4 Roche B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Roche Recent Developments and Future Plans
    2.2 Gilead Sciences
        2.2.1 Gilead Sciences Details
        2.2.2 Gilead Sciences Major Business
        2.2.3 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.2.4 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Gilead Sciences Recent Developments and Future Plans
    2.3 TG Therapeutics
        2.3.1 TG Therapeutics Details
        2.3.2 TG Therapeutics Major Business
        2.3.3 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.3.4 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 TG Therapeutics Recent Developments and Future Plans
    2.4 Bayer
        2.4.1 Bayer Details
        2.4.2 Bayer Major Business
        2.4.3 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.4.4 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Bayer Recent Developments and Future Plans
    2.5 Secura Bio
        2.5.1 Secura Bio Details
        2.5.2 Secura Bio Major Business
        2.5.3 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.5.4 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Secura Bio Recent Developments and Future Plans
    2.6 Epizyme
        2.6.1 Epizyme Details
        2.6.2 Epizyme Major Business
        2.6.3 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.6.4 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Epizyme Recent Developments and Future Plans
    2.7 Eisai
        2.7.1 Eisai Details
        2.7.2 Eisai Major Business
        2.7.3 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.7.4 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Eisai Recent Developments and Future Plans
    2.8 Acrotech Biopharma
        2.8.1 Acrotech Biopharma Details
        2.8.2 Acrotech Biopharma Major Business
        2.8.3 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.8.4 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Acrotech Biopharma Recent Developments and Future Plans
    2.9 Teva
        2.9.1 Teva Details
        2.9.2 Teva Major Business
        2.9.3 Teva B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.9.4 Teva B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Teva Recent Developments and Future Plans
    2.10 Eagle Pharmaceuticals
        2.10.1 Eagle Pharmaceuticals Details
        2.10.2 Eagle Pharmaceuticals Major Business
        2.10.3 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.10.4 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Eagle Pharmaceuticals Recent Developments and Future Plans
    2.11 MundiPharma
        2.11.1 MundiPharma Details
        2.11.2 MundiPharma Major Business
        2.11.3 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
        2.11.4 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 MundiPharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 B-Cell Non-Hodgkin's Lymphoma Drug Players Market Share
        3.2.2 Top 10 B-Cell Non-Hodgkin's Lymphoma Drug Players Market Share
        3.2.3 Market Competition Trend
    3.3 B-Cell Non-Hodgkin's Lymphoma Drug Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Market Share by Type (2016-2021)
    4.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Application (2016-2021)
    5.2 B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2016-2026)
    6.2 North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2026)
    6.3 North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country
        6.3.1 North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2016-2026)
        6.3.2 United States B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        6.3.3 Canada B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        6.3.4 Mexico B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2016-2026)
    7.2 Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2026)
    7.3 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country
        7.3.1 Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2016-2026)
        7.3.2 Germany B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        7.3.3 France B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        7.3.5 Russia B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        7.3.6 Italy B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2016-2026)
    8.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2026)
    8.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region
        8.3.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Region (2016-2026)
        8.3.2 China B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        8.3.3 Japan B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        8.3.4 South Korea B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        8.3.5 India B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        8.3.7 Australia B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2016-2026)
    9.2 South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2026)
    9.3 South America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country
        9.3.1 South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2016-2026)
        9.3.2 Brazil B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        9.3.3 Argentina B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2016-2026)
    10.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2026)
    10.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country
        10.3.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2016-2026)
        10.3.2 Turkey B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)
        10.3.4 UAE B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market B-Cell Non-Hodgkin's Lymphoma Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million) by Region (2016-2021)
    Table 5. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2021-2026)
    Table 6. Roche Corporate Information, Head Office, and Major Competitors
    Table 7. Roche Major Business
    Table 8. Roche B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 9. Roche B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Gilead Sciences Corporate Information, Head Office, and Major Competitors
    Table 11. Gilead Sciences Major Business
    Table 12. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 13. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. TG Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 15. TG Therapeutics Major Business
    Table 16. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 17. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Bayer Corporate Information, Head Office, and Major Competitors
    Table 19. Bayer Major Business
    Table 20. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 21. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Secura Bio Corporate Information, Head Office, and Major Competitors
    Table 23. Secura Bio Major Business
    Table 24. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 25. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Epizyme Corporate Information, Head Office, and Major Competitors
    Table 27. Epizyme Major Business
    Table 28. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 29. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Eisai Corporate Information, Head Office, and Major Competitors
    Table 31. Eisai Major Business
    Table 32. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 33. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Acrotech Biopharma Corporate Information, Head Office, and Major Competitors
    Table 35. Acrotech Biopharma Major Business
    Table 36. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 37. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Teva Corporate Information, Head Office, and Major Competitors
    Table 39. Teva Major Business
    Table 40. Teva B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 41. Teva B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Eagle Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 43. Eagle Pharmaceuticals Major Business
    Table 44. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 45. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. MundiPharma Corporate Information, Head Office, and Major Competitors
    Table 47. MundiPharma Major Business
    Table 48. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
    Table 49. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million) by Players (2019-2021)
    Table 51. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Share by Players (2019-2021)
    Table 52. Breakdown of B-Cell Non-Hodgkin's Lymphoma Drug by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 53. B-Cell Non-Hodgkin's Lymphoma Drug Players Head Office, Products and Services Provided
    Table 54. B-Cell Non-Hodgkin's Lymphoma Drug Mergers & Acquisitions in the Past Five Years
    Table 55. B-Cell Non-Hodgkin's Lymphoma Drug New Entrants and Expansion Plans
    Table 56. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million) by Type (2016-2021)
    Table 57. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Share by Type (2016-2021)
    Table 58. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Forecast by Type (2021-2026)
    Table 59. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2021)
    Table 60. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Forecast by Application (2021-2026)
    Table 61. North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2016-2021) & (USD Million)
    Table 62. North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2021-2026) & (USD Million)
    Table 63. North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2021) & (USD Million)
    Table 64. North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2021-2026) & (USD Million)
    Table 65. North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2016-2021) & (USD Million)
    Table 66. North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2021-2026) & (USD Million)
    Table 67. Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2016-2021) & (USD Million)
    Table 68. Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2021-2026) & (USD Million)
    Table 69. Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2021) & (USD Million)
    Table 70. Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2021-2026) & (USD Million)
    Table 71. Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2016-2021) & (USD Million)
    Table 72. Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2021-2026) & (USD Million)
    Table 73. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2016-2021) & (USD Million)
    Table 74. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2021-2026) & (USD Million)
    Table 75. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2021) & (USD Million)
    Table 76. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2021-2026) & (USD Million)
    Table 77. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Region (2016-2021) & (USD Million)
    Table 78. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Region (2021-2026) & (USD Million)
    Table 79. South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2016-2021) & (USD Million)
    Table 80. South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2021-2026) & (USD Million)
    Table 81. South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2021) & (USD Million)
    Table 82. South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2021-2026) & (USD Million)
    Table 83. South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2016-2021) & (USD Million)
    Table 84. South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2021-2026) & (USD Million)
    Table 85. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2016-2021) & (USD Million)
    Table 86. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Type (2021-2026) & (USD Million)
    Table 87. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2016-2021) & (USD Million)
    Table 88. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Application (2021-2026) & (USD Million)
    Table 89. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2016-2021) & (USD Million)
    Table 90. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. B-Cell Non-Hodgkin's Lymphoma Drug Picture
    Figure 2. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Type in 2020
    Figure 3. Oral
    Figure 4. Injection
    Figure 5. B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Application in 2020
    Figure 6. Hospital Picture
    Figure 7. Retail Pharmacy Picture
    Figure 8. Other Picture
    Figure 9. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 10. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Forecast (2016-2026) & (USD Million)
    Figure 11. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2016-2026)
    Figure 12. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region in 2020
    Figure 13. North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 14. Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. B-Cell Non-Hodgkin's Lymphoma Drug Market Drivers
    Figure 19. B-Cell Non-Hodgkin's Lymphoma Drug Market Restraints
    Figure 20. B-Cell Non-Hodgkin's Lymphoma Drug Market Trends
    Figure 21. Roche Recent Developments and Future Plans
    Figure 22. Gilead Sciences Recent Developments and Future Plans
    Figure 23. TG Therapeutics Recent Developments and Future Plans
    Figure 24. Bayer Recent Developments and Future Plans
    Figure 25. Secura Bio Recent Developments and Future Plans
    Figure 26. Epizyme Recent Developments and Future Plans
    Figure 27. Eisai Recent Developments and Future Plans
    Figure 28. Acrotech Biopharma Recent Developments and Future Plans
    Figure 29. Teva Recent Developments and Future Plans
    Figure 30. Eagle Pharmaceuticals Recent Developments and Future Plans
    Figure 31. MundiPharma Recent Developments and Future Plans
    Figure 32. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Share by Players in 2020
    Figure 33. B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 34. Global Top 3 Players B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share in 2020
    Figure 35. Global Top 10 Players B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share in 2020
    Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 37. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Share by Type in 2020
    Figure 38. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share Forecast by Type (2021-2026)
    Figure 39. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Share by Application in 2020
    Figure 40. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share Forecast by Application (2021-2026)
    Figure 41. North America B-Cell Non-Hodgkin's Lymphoma Drug Sales Market Share by Type (2016-2026)
    Figure 42. North America B-Cell Non-Hodgkin's Lymphoma Drug Sales Market Share by Application (2016-2026)
    Figure 43. North America B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Country (2016-2026)
    Figure 44. United States B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Canada B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Mexico B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Europe B-Cell Non-Hodgkin's Lymphoma Drug Sales Market Share by Type (2016-2026)
    Figure 48. Europe B-Cell Non-Hodgkin's Lymphoma Drug Sales Market Share by Application (2016-2026)
    Figure 49. Europe B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Country (2016-2026)
    Figure 50. Germany B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. France B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. United Kingdom B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Russia B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Italy B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Sales Market Share by Type (2016-2026)
    Figure 56. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Sales Market Share by Application (2016-2026)
    Figure 57. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2016-2026)
    Figure 58. China B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Japan B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. South Korea B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. India B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Southeast Asia B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Australia B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. South America B-Cell Non-Hodgkin's Lymphoma Drug Sales Market Share by Type (2016-2026)
    Figure 65. South America B-Cell Non-Hodgkin's Lymphoma Drug Sales Market Share by Application (2016-2026)
    Figure 66. South America B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Country (2016-2026)
    Figure 67. Brazil B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Argentina B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Drug Sales Market Share by Type (2016-2026)
    Figure 70. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Drug Sales Market Share by Application (2016-2026)
    Figure 71. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Country (2016-2026)
    Figure 72. Turkey B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Saudi Arabia B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. UAE B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Methodology
    Figure 76. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Roche
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
Epizyme
Eisai
Acrotech Biopharma
Teva
Eagle Pharmaceuticals
MundiPharma

Related Reports

Global B-Cell Non-Hodgkin's Lymphoma Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global B-Cell Non-Hodgkin's Lymphoma Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 17 Jan 2022

date Pharma & Healthcare

The B-Cell Non-Hodgkin's Lymphoma Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

b cell non hodgkin's lymphoma drug

B-Cell Non-Hodgkin's Lymphoma Drug

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>